Literature DB >> 19460946

Involvement of Vitamin D receptor in the intestinal induction of human ABCB1.

Shuko Tachibana1, Kouichi Yoshinari, Tsubasa Chikada, Takayoshi Toriyabe, Kiyoshi Nagata, Yasushi Yamazoe.   

Abstract

ABCB1 (P-glycoprotein) is an efflux transporter that limits the cellular uptake levels of various drugs in intestine, brain, and other tissues. The expression of human ABCB1 has recently been reported to be under the control of nuclear receptor NR1I subfamily members, pregnane X receptor (PXR, NR1I2) and constitutive androstane receptor (CAR, NR1I3). Here, we have investigated the involvement of another NR1I member, vitamin D receptor (VDR, NR1I1), in ABCB1 expression. In the human colorectal adenocarcinoma cell line LS174T, which abundantly expresses VDR, both 1alpha,25-dihydroxyvitamin D(3) (1,25-VD3) and lithocholic acid (LCA) increased ABCB1 mRNA levels. Reporter gene assays in LS174T cells with constructs containing various lengths of the ABCB1 regulatory region revealed that the region containing multiple nuclear receptor binding motifs located at -7.8 kilobases [termed nuclear receptor-responsive module (NURREM)], to which PXR and CAR also bind, is essential for the VDR-mediated ABCB1 transactivation. Further reporter assays with constructs containing truncated NURREM and gel shift assays suggested simultaneous binding of multiple VDR/retinoid X receptor alpha heterodimers to NURREM. Furthermore, knockdown of VDR expression in LS174T cells blocked the LCA- and the 1,25-VD3-induced transcription of ABCB1 reporter genes. In human hepatoma HepG2 cells, in contrast with LS174T cells, 1,25-VD3 activated the ABCB1 transcription only in the presence of ectopically expressed VDR. These results suggest that the NR1I subfamily members regulate the ABCB1 expression sharing the binding sites within NURREM and that the physiologically produced LCA and 1,25-VD3 may modulate the ABCB1 expression in human intestines, possibly associated with interindividual variations of ABCB1 expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460946     DOI: 10.1124/dmd.109.027219

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  13 in total

1.  Nuclear Receptors in Drug Metabolism, Drug Response and Drug Interactions.

Authors:  Chandra Prakash; Baltazar Zuniga; Chung Seog Song; Shoulei Jiang; Jodie Cropper; Sulgi Park; Bandana Chatterjee
Journal:  Nucl Receptor Res       Date:  2015

2.  Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).

Authors:  Laura M Hodges; Svetlana M Markova; Leslie W Chinn; Jason M Gow; Deanna L Kroetz; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-03       Impact factor: 2.089

3.  A synthetic lethal screen identifies the Vitamin D receptor as a novel gemcitabine sensitizer in pancreatic cancer cells.

Authors:  V Bhattacharjee; Y Zhou; T J Yen
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 4.  Significance of the Vitamin D Receptor on Crosstalk with Nuclear Receptors and Regulation of Enzymes and Transporters.

Authors:  Keumhan Noh; Edwin C Y Chow; Holly P Quach; Geny M M Groothuis; Rommel G Tirona; K Sandy Pang
Journal:  AAPS J       Date:  2022-06-01       Impact factor: 3.603

5.  Corepressors (NCoR and SMRT) as well as coactivators are recruited to positively regulated 1α,25-dihydroxyvitamin D3-responsive genes.

Authors:  Mark B Meyer; J Wesley Pike
Journal:  J Steroid Biochem Mol Biol       Date:  2012-08-25       Impact factor: 4.292

6.  Food dyes as P-glycoprotein modulators.

Authors:  Jack W Staples; Jessica M Stine; Eero Mäki-Lohiluoma; Emily Steed; Kathleen M George; Charles M Thompson; Erica L Woodahl
Journal:  Food Chem Toxicol       Date:  2020-10-01       Impact factor: 6.023

7.  Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.

Authors:  Vibeke Andersen; Katrine Svenningsen; Lina Almind Knudsen; Axel Kornerup Hansen; Uffe Holmskov; Allan Stensballe; Ulla Vogel
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

8.  Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.

Authors:  Murielle Bochud; Michel Burnier; Idris Guessous
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-12

Review 9.  Sucralose, a synthetic organochlorine sweetener: overview of biological issues.

Authors:  Susan S Schiffman; Kristina I Rother
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2013       Impact factor: 6.393

Review 10.  Developments in renal pharmacogenomics and applications in chronic kidney disease.

Authors:  Ariadna Padullés; Inés Rama; Inés Llaudó; Núria Lloberas
Journal:  Pharmgenomics Pers Med       Date:  2014-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.